Lynne Terry

Medicaid Insurer Offers Opioid Addiction Treatment On Oregon Coast

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

A first-of-its-kind clinic just opened on the north Oregon Coast to provide opioid addiction treatment in an area that’s been hard hit by opioid-related deaths.

Unity Center Delays Reporting Abuse, Stirs Concern About Patient Treatment, Documents Show

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

UPDATED: Monday, Jan. 23 at 6:40 p.m.

Survey: Sexual Harassment, Discrimination Pervasive At OHSU

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

Oregon Health & Science University has a problem with sexual harassment and discrimination, according to a survey of staff and students. 

Study Shows How Pharmaceutical Companies Maneuver To Maintain Sales, High Prices

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

When a generic multiple sclerosis drug hit the U.S. market in 2015, observers expected it could push down prices in a class of drugs that has skyrocketed in recent years. 

That did not happen. 

Pages

Subscribe to Lynne Terry